Duygu Bayir Garbioglu

发表

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

O. Avci, Mustafa YILMAZ, S. Paydaş, 2022, Anti-cancer drugs.

Determination of therapeutic agents efficiencies of microsatellite instability high colon cancer cells in post‐metastatic liver biochip modeling

H. Avci, M. Dinçer, N. Demir, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Impact of COVID-19 on Anxiety Levels of Cancer Patients

Duygu Bayir Garbioglu, 2022, Eurasian Journal of Medical Investigation.

Does Haematological Toxicity Increase with the Use of Lipophilic Chemotherapeutic Agents in Obese Breast Cancer Patients?

Duygu Bayir Garbioglu, 2024, Eurasian Journal of Medical Investigation.